Beyond Bulls & Bears

In the Know: What’s Ailing US Biotech?
Equity

In the Know: What’s Ailing US Biotech?

Even if Hillary Clinton’s prescription plan, as we currently understand it, did ultimately pass, in my view the impact would be very manageable for the (biotech) sector.